Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2024 Filed Apr 17, 2024 20:33 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 5,834 | $66.20 | $386,210.80 |
DisclosureSEC source: 0001870913-24-000014 · wk-form4_1713385980.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 819,372 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The shares were sold in multiple trades at prices ranging from $66.01 to $66.58. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:33 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 7,414 | $66.33 | $491,770.62 |
DisclosureSEC source: 0001870913-24-000014 · wk-form4_1713385980.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 825,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $65.65 to $67.27. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 22:28 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $67.79 | $16,947.50 |
DisclosureSEC source: 0001938861-24-000012 · wk-form4_1713220119.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,731 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 01:13 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 2,799 | $66.96 | $187,421.04 |
DisclosureSEC source: 0001579587-24-000011 · wk-form4_1712884382.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,006 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 01:12 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 4,534 | $66.96 | $303,596.64 |
DisclosureSEC source: 0001674236-24-000011 · wk-form4_1712884344.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,968 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:59 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $67.25 | $1,345,000.00 |
DisclosureSEC source: 0001871002-24-000008 · wk-form4_1712098747.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 253,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $66.50 to $69.05. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| March 23, 2024 Filed Mar 25, 2024 20:14 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 3,653 | $69.58 | $254,175.74 |
DisclosureSEC source: 0001579587-24-000009 · wk-form4_1711397661.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,805 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2024 Filed Mar 25, 2024 20:17 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 6,210 | $69.58 | $432,091.80 |
DisclosureSEC source: 0001674236-24-000009 · wk-form4_1711397817.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,502 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2024 Filed Mar 25, 2024 20:09 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 17,455 | $69.58 | $1,214,518.90 |
DisclosureSEC source: 0001822629-24-000008 · wk-form4_1711397380.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,174 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 13, 2024 Filed Mar 13, 2024 20:48 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $66.54 | $16,635.00 |
DisclosureSEC source: 0001938861-24-000010 · wk-form4_1710362889.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,981 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| March 11, 2024 Filed Mar 11, 2024 22:39 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 7,787 | $65.55 | $510,437.85 |
DisclosureSEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,712 F2 · price: The shares were sold in multiple trades at prices ranging from $65.08 to $66.63. The price reported above reflects the weighted average sales price. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:44 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $65.81 | $1,316,200.00 |
DisclosureSEC source: 0001871002-24-000006 · wk-form4_1710362669.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 273,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $65.23 to $66.34. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| March 08, 2024 Filed Mar 9, 2024 00:25 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 16,292 | $67.13 | $1,093,681.96 |
DisclosureSEC source: 0001822629-24-000006 · wk-form4_1709943903.xml · nonDerivative · entry 3 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,629 F3 · price: The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:43 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,000 | $67.17 | $671,700.00 |
DisclosureSEC source: 0001870913-24-000012 · wk-form4_1710196991.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 832,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $66.51 to $67.81, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:42 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 2,034 | $66.71 | $135,688.14 |
DisclosureSEC source: 0001579587-24-000006 · wk-form4_1709865716.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,458 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,644 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:42 UTC |
Marken James G.SVP OPS & PROD DEV
|
SaleCommon Stock | 24,338 | $66.37 | $1,615,313.06 |
DisclosureSEC source: 0001579587-24-000006 · wk-form4_1709865716.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,492 F1 · price: The shares were sold in multiple trades at prices ranging from $66.00 to $66.75. The price reported above reflects the weighted average sales price. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:21 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 2,494 | $66.71 | $166,374.74 |
DisclosureSEC source: 0001846478-24-000009 · wk-form4_1709864464.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,212 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:16 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 2,110 | $66.71 | $140,758.10 |
DisclosureSEC source: 0001846487-24-000010 · wk-form4_1709864200.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,277 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 15,085 | $66.35 | $1,000,889.75 |
DisclosureSEC source: 0001870913-24-000010 · wk-form4_1709863910.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 842,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $65.53 to $67.00, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 00:25 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 17,060 | $66.71 | $1,138,072.60 |
DisclosureSEC source: 0001822629-24-000006 · wk-form4_1709943903.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,921 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:39 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 4,216 | $66.71 | $281,249.36 |
DisclosureSEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,499 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 02:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 14,822 | $65.47 | $970,396.34 |
DisclosureSEC source: 0001870913-24-000010 · wk-form4_1709863910.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 857,705 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.84 to $66.04, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:25 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 28,965 | $65.52 | $1,897,786.80 |
DisclosureSEC source: 0001822629-24-000006 · wk-form4_1709943903.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,981 F1 · price: The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:24 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 5,000 | $66.00 | $330,000.00 |
DisclosureSEC source: 0001846487-24-000008 · wk-form4_1709760262.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,387 F1 · price: The shares were sold in multiple trades at prices ranging from $65.77 to $66.49. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,093 | $65.35 | $659,577.55 |
DisclosureSEC source: 0001870913-24-000010 · wk-form4_1709863910.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 872,527 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.45 to $66.58, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:20 UTC |
Pera Antonio RDirector
|
SaleCommon Stock | 7,000 | $65.20 | $456,400.00 |
DisclosureSEC source: 0001689325-24-000002 · wk-form4_1709760008.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,627 Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:18 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
Tax withholdingCommon Stock | 1,122 | $67.67 | $75,925.74 |
DisclosureSEC source: 0001870913-24-000008 · wk-form4_1709331498.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,652 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:12 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,275 | $67.67 | $86,279.25 |
DisclosureSEC source: 0001846487-24-000006 · wk-form4_1709331156.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,387 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:09 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 1,058 | $67.67 | $71,594.86 |
DisclosureSEC source: 0001579587-24-000004 · wk-form4_1709330942.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,830 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,256 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:06 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 10,014 | $67.67 | $677,647.38 |
DisclosureSEC source: 0001822629-24-000004 · wk-form4_1709330802.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,946 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,882 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:03 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,570 | $67.67 | $106,241.90 |
DisclosureSEC source: 0001846478-24-000007 · wk-form4_1709330627.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,706 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:01 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
Tax withholdingCommon Stock | 1,635 | $67.67 | $110,640.45 |
DisclosureSEC source: 0001871002-24-000004 · wk-form4_1709330494.xml · nonDerivative · entry 1 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,679 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:59 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
Tax withholdingCommon Stock | 1,173 | $67.67 | $79,376.91 |
DisclosureSEC source: 0001946439-24-000004 · wk-form4_1709330377.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,545 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:57 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 1,173 | $67.67 | $79,376.91 |
DisclosureSEC source: 0001938861-24-000008 · wk-form4_1709330246.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,231 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:55 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 1,914 | $67.67 | $129,520.38 |
DisclosureSEC source: 0001674236-24-000005 · wk-form4_1709330090.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,715 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:09 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,244 | $57.55 | $71,592.20 |
DisclosureSEC source: 0001846478-24-000005 · wk-form4_1708466883.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,276 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,227 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:02 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,261 | $57.55 | $72,570.55 |
DisclosureSEC source: 0001846487-24-000004 · wk-form4_1708466458.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,662 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:56 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 53,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001822629-24-000002 · wk-form4_1708120602.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,960 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:56 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 80,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001822629-24-000002 · wk-form4_1708120602.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,274 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:53 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 8,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001870913-24-000006 · wk-form4_1708120376.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,774 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:53 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 13,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001870913-24-000006 · wk-form4_1708120376.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,828 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:50 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 12,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001846487-24-000002 · wk-form4_1708120221.xml · nonDerivative · entry 2 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,923 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:50 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 18,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001846487-24-000002 · wk-form4_1708120221.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,397 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:34 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 8,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001871002-24-000002 · wk-form4_1708119272.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,314 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:34 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 13,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001871002-24-000002 · wk-form4_1708119272.xml · nonDerivative · entry 1 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,368 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:47 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 6,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001579587-24-000002 · wk-form4_1708120015.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,888 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:47 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 10,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001579587-24-000002 · wk-form4_1708120015.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,178 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:38 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 9,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-24-000003 · wk-form4_1708119468.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,520 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:38 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 14,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-24-000003 · wk-form4_1708119468.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,678 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:30 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 8,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001946439-24-000002 · wk-form4_1708119020.xml · nonDerivative · entry 2 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,718 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.